XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENT OF EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative effect of changes in accounting principle
Ideanomics Shareholders’ equity
Ideanomics Shareholders’ equity
Cumulative effect of changes in accounting principle
Common Stock
Additional Paid-in  Capital
Accumulated Deficit
Accumulated Deficit
Cumulative effect of changes in accounting principle
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning balance (in shares) at Dec. 31, 2021         3,978,180          
Beginning balance at Dec. 31, 2021 $ 365,368   $ 363,027   $ 497 $ 968,066 $ (605,758)   $ 222 $ 2,341
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation 2,355   2,355     2,355        
Common stock issuance for professional fee (in shares)         2,800          
Common stock issuance for professional fee 435   435   $ 1 434        
Tax withholding paid for net share settlement of equity awards (83)   (83)     (83)        
Common stock issued under employee stock incentive plan (in shares)         1,000          
Common stock issued under employee stock incentive plan 66   66     66        
Deconsolidation of subsidiary (236)                 (236)
Acquisition of Energica 24,778                 24,778
Net loss (29,092)   (28,512)       (28,512)     (580)
Foreign currency translation adjustments 1,209   925           925 284
Ending balance (in shares) at Mar. 31, 2022         3,981,980          
Ending balance at Mar. 31, 2022 364,800   338,213   $ 498 970,838 (634,270)   1,147 26,587
Beginning balance (in shares) at Dec. 31, 2021         3,978,180          
Beginning balance at Dec. 31, 2021 365,368   363,027   $ 497 968,066 (605,758)   222 2,341
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustments (7,803)                  
Ending balance (in shares) at Jun. 30, 2022         3,981,980          
Ending balance at Jun. 30, 2022 319,427   296,471   $ 498 973,701 (672,037)   (5,691) 22,956
Beginning balance (in shares) at Dec. 31, 2021         3,978,180          
Beginning balance at Dec. 31, 2021 $ 365,368   363,027   $ 497 968,066 (605,758)   222 2,341
Ending balance (in shares) at Dec. 31, 2022 4,786,289.768       4,781,930          
Ending balance at Dec. 31, 2022 $ 136,451 $ (332) 132,125 $ (332) $ 597 1,004,082 (866,450) $ (332) (6,104) 4,326
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accounting standards update, extensible enumeration Accounting Standards Update 2016-13 [Member]                  
Beginning balance (in shares) at Mar. 31, 2022         3,981,980          
Beginning balance at Mar. 31, 2022 $ 364,800   338,213   $ 498 970,838 (634,270)   1,147 26,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation 2,863   2,863     2,863        
Common stock issuance for acquisition 49                 49
Net loss (39,273)   (37,767)       (37,767)     (1,506)
Foreign currency translation adjustments (9,012)   (6,838)           (6,838) (2,174)
Ending balance (in shares) at Jun. 30, 2022         3,981,980          
Ending balance at Jun. 30, 2022 $ 319,427   296,471   $ 498 973,701 (672,037)   (5,691) 22,956
Beginning balance (in shares) at Dec. 31, 2022 4,786,289.768       4,781,930          
Beginning balance at Dec. 31, 2022 $ 136,451 (332) 132,125 (332) $ 597 1,004,082 (866,450) (332) (6,104) 4,326
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation 2,470   2,470     2,470        
Dividend accrued for Preferred Stock Series B (214)   (214)     (214)        
Preferred stock series B warrants (17,402)   (17,402)     (17,402)        
Common stock issuance for acquisition (in shares)         1,011,372          
Common stock issuance for acquisition 26,308   26,308   $ 126 26,182        
Common stock issuance for professional fee (in shares)         234,239          
Common stock issuance for professional fee 3,377   3,377   $ 29 3,348        
Tax withholding paid for net share settlement of equity awards (in shares)         21,359          
Tax withholding paid for net share settlement of equity awards (354)   (354)   $ 3 (357)        
Common stock issuance for preferred stock Series B conversion (in shares)         392,157          
Common stock issuance for preferred stock Series B conversion 8,850   8,850   $ 49 8,801        
Share issuance pertinent to SEPA (in shares)         885,733          
Share issuance pertinent to SEPA 15,157   15,157   $ 111 15,046        
RSUs issued to employees (in shares)         4,800          
RSUs issued to employees 0       $ 1 (1)        
Net loss (85,892)   (84,317)       (84,317)     (1,575)
Foreign currency translation adjustments 1,361   1,056           1,056 305
Ending balance (in shares) at Mar. 31, 2023         7,331,590          
Ending balance at Mar. 31, 2023 $ 89,780   86,724   $ 916 1,041,955 (951,099)   (5,048) 3,056
Beginning balance (in shares) at Dec. 31, 2022 4,786,289.768       4,781,930          
Beginning balance at Dec. 31, 2022 $ 136,451 $ (332) 132,125 $ (332) $ 597 1,004,082 (866,450) $ (332) (6,104) 4,326
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustments $ 825                  
Ending balance (in shares) at Jun. 30, 2023 10,976,787       11,264,709          
Ending balance at Jun. 30, 2023 $ 79,126   78,324   $ 1,408 1,068,697 (986,596)   (5,185) 802
Beginning balance (in shares) at Mar. 31, 2023         7,331,590          
Beginning balance at Mar. 31, 2023 89,780   86,724   $ 916 1,041,955 (951,099)   (5,048) 3,056
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation 1,816   1,816     1,816        
Dividend accrued for Preferred Stock Series B (130)   (130)     (130)        
Common stock issuance for series B preferred stock warrants exercise (in shares)         3,191,555          
Common stock issuance for warrants exercise 17,516   17,516   $ 399 17,117        
Warrants expiration 1,037   1,037     1,037        
Common stock issuance for professional fee (in shares)         173,542          
Common stock issuance for professional fee 1,058   1,058   $ 22 1,036        
Common stock issuance for preferred stock Series B conversion (in shares)         280,422          
Common stock issuance for preferred stock Series B conversion 3,540   3,540   $ 35 3,505        
Share issuance pertinent to SEPA (in shares)         167,600          
Share issuance pertinent to SEPA 897   897   $ 21 876        
RSUs issued to employees (in shares)         120,000          
RSUs issued to employees 1,500   1,500   $ 15 1,485        
Non-controlling shareholders withdraw (263)                 (263)
Net loss (37,089)   (35,497)       (35,497)     (1,592)
Foreign currency translation adjustments $ (536)   (137)           (137) (399)
Ending balance (in shares) at Jun. 30, 2023 10,976,787       11,264,709          
Ending balance at Jun. 30, 2023 $ 79,126   $ 78,324   $ 1,408 $ 1,068,697 $ (986,596)   $ (5,185) $ 802